ProfileGDS5822 / ILMN_2671689
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 73% 78% 71% 73% 78% 80% 73% 72% 71% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 166.273
GSM1276600PDAC Late Ablation Control 2125.778
GSM1276601PDAC Late Ablation Control 380.671
GSM1276602PDAC Late Ablation 16673
GSM1276603PDAC Late Ablation 2130.978
GSM1276604PDAC Late Ablation 3149.780
GSM1303940PDAC Late Ablation_anti-CTLA4 165.973
GSM1303941PDAC Late Ablation_anti-CTLA4 278.972
GSM1303942PDAC Late Ablation_anti-CTLA4 377.471